PR95312

TEL AVIV, Israel, April 4, 2022 /PRNewswire=KYODO JBN/ --

Radiaction Medical Ltd. [ http://www.radiactionmedical.com/  ] ("Radiaction"),

an innovative medical device company focused on radiation protection in the

interventional cardiology and electrophysiology sectors, announced FDA 510(K)

clearance for the marketing of its Shield System in the US.

In addition, the company has completed a $10 million round of financing led by

current investors, InnovaHealth Partners. Proceeds will be used to launch

Radiaction's Shield System in the US and to further commercialize in Europe.

Individuals working in catheterization laboratories ("cath labs") are exposed

to high levels of scattered radiation generated from the use of X-ray

fluoroscopy. The medical teams wear heavy lead aprons for protection, but their

heads, arms and legs are unprotected, leading to an increase in risk for brain

tumors, cognitive degradation and other radiation-related illnesses. In

addition, the heavy lead aprons can cause severe orthopedic injuries. A

significant part of the radiation is scattered throughout the cath lab by its

interaction with the patient's body and X-ray table. Mounted directly on the

C-arm, Radiaction's Shield System blocks and captures the scattered radiation

at the source. Clinical studies demonstrate that the device reduces radiation

in the entire cath lab by over 90%, with even higher reduction rates to the

head and upper body of all personnel in the room.

Jonathan Yifat, Radiaction's CEO, said, "We are very pleased with the FDA

clearance of our device and look forward to protecting the physicians and

medical personnel performing interventional procedures in the US. This

financing will drive our commercialization in the US and Europe, and allow us

to build our team and market presence. We are excited to take this next step

with our long-time partner, InnovaHealth Partners, who has tremendous

experience backing the fast commercial growth of technology companies."

About Radiaction:

Radiaction, based in Tel Aviv, Israel, has developed the Shield System to

provide a radiation-safe environment for the entire healthcare team. The

Company is revolutionizing X-ray protection by providing full-body shielding to

all medical personnel during fluoroscopy-guided procedures. Placed on the

C-arm, the Shield System encapsulates the imaging beam and blocks the scattered

radiation at its origin, creating a paradigm shift in medical staff radiation

protection. First installations will target the Interventional Cardiology and

Electrophysiology markets, where physicians experience the highest radiation

exposure.

Radiaction was founded by Amir Belson, MD and its lead investor is InnovaHealth

Partners, LP.

For more information, visit Radiaction's website at www.radiactionmedical.com

or send an email to: contact@radiactionmedical.com.

Source: Radiaction Medical Ltd.